4.6 Article

The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1

Journal

JOURNAL OF VIROLOGY
Volume 91, Issue 9, Pages -

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.02114-16

Keywords

Epstein-Barr virus; DNA polymerase accessory factor; BMRF1; chromatin regulator; BRG1; transcriptional regulation

Categories

Funding

  1. Ministry of Science and Technology, Taiwan (MOST) [NSC 101-2320-B-002-031-MY3, MOST-104-2320-B-002-054-MY3]
  2. National Health Research Institutes (NHRI)
  3. National Taiwan University College of Medicine [NHRI-EX105-10201BI, 105C101-A2, 106C101-F2]
  4. [MOST-104-2811-B-002-115]
  5. [MOST-105-2811-B-002-085]

Ask authors/readers for more resources

During the lytic phase of Epstein-Barr virus (EBV), binding of the transactivator Zta to the origin of lytic replication (oriLyt) and the BHLF1 transcript, forming a stable RNA-DNA hybrid, is required to initiate viral DNA replication. EBV-encoded viral DNA replication proteins form complexes to amplify viral DNA. BMRF1, the viral DNA polymerase accessory factor, is essential for lytic DNA replication and also known as a transcriptional regulator of the expression of BHLF1 and BALF2 (single-stranded DNA [ssDNA]-binding protein). In order to determine systematically how BMRF1 regulates viral transcription, a BMRF1 knockout bacmid was generated to analyze viral gene expression using a viral DNA microarray. We found that a subset of Rta-responsive late genes, including BcLF1, BLLF1, BLLF2, and BDLF3, were downregulated in cells harboring a BMRF1 knockout EBV bacmid (p2089 Delta BMRF1). In reporter assays, BMRF1 appears to transactivate a subset of viral late promoters through distinct pathways. BMRF1 activates the BDLF3 promoter in an SP1-dependent manner. Notably, BMRF1 associates with the transcriptional regulator BRG1 in EBV-reactivated cells. BMRF1-mediated transactivation activities on the BcLF1 and BLLF1 promoters were attenuated by knockdown of BRG1. In BRG1-depleted EBV-reactivated cells, BcLF1 and BLLF1 transcripts were reduced in number, resulting in reduced virion secretion. BMRF1 and BRG1 bound to the adjacent upstream regions of the BcLF1 and BLLF1 promoters, and depletion of BRG1 attenuated the recruitment of BMRF1 onto both promoters, suggesting that BRG1 is involved in BMRF1-mediated regulation of these two genes. Overall, we reveal a novel pathway by which BMRF1 can regulate viral promoters through interaction with BRG1. IMPORTANCE The cascade of viral gene expression during Epstein-Barr virus (EBV) replication is exquisitely regulated by the coordination of the viral DNA replication machinery and cellular factors. Upon lytic replication, the EBV immediate early proteins Zta and Rta turn on the expression of early proteins that assemble into viral DNA replication complexes. The DNA polymerase accessory factor, BMRF1, also is known to transactivate early gene expression through its interaction with SP1 or Zta on specific promoters. Through a global analysis, we demonstrate that BMRF1 also turns on a subset of Rta-regulated, late structural gene promoters. Searching for BMRF1-interacting cellular partners revealed that the SWI/SNF chromatin modifier BRG1 contributes to BMRF1-mediated transactivation of a subset of late promoters through protein-protein interaction and viral chromatin binding. Our findings indicate that BMRF1 regulates the expression of more viral genes than thought previously through distinct viral DNA replication-independent mechanisms.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pharmacology & Pharmacy

Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes

Chung-Chun Wu, Chih-Yeu Fang, Hui-Yu Hsu, Yen-Ju Chen, Sheng-Ping Chou, Sheng-Yen Huang, Yu-Jhen Cheng, Su-Fang Lin, Yao Chang, Ching-Hwa Tsai, Jen-Yang Chen

ANTIVIRAL RESEARCH (2016)

Article Virology

The Ubiquitin Ligase Itch and Ubiquitination Regulate BFRF1-Mediated Nuclear Envelope Modification for Epstein-Barr Virus Maturation

Chung-Pei Lee, Guan-Ting Liu, Hsiu-Ni Kung, Po-Ting Liu, Yen-Tzu Liao, Lu-Ping Chow, Ling-Shih Chang, Yu-Hsin Chang, Chou-Wei Chang, Wen-Chi Shu, Annie Angers, Antonella Farina, Su-Fang Lin, Ching-Hwa Tsai, Fadila Bouamr, Mei-Ru Chen

JOURNAL OF VIROLOGY (2016)

Article Oncology

EBV reactivation as a target of luteolin to repress NPC tumorigenesis

Chung-Chun Wu, Chih-Yeu Fang, Hui-Yu Hsu, Hsin-Ying Chuang, Yu-Jhen Cheng, Yen-Ju Chen, Sheng-Ping Chou, Sheng-Yen Huang, Su-Fang Lin, Yao Chang, Ching-Hwa Tsai, Jen-Yang Chen

ONCOTARGET (2016)

Article Virology

Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes

Yen-Ju Chen, Yu-Lian Chen, Yao Chang, Chung-Chun Wu, Ying-Chieh Ko, Sai Wah Tsao, Jen-Yang Chen, Su-Fang Lin

JOURNAL OF VIROLOGY (2017)

Article Oncology

Epstein-Barr virus BRLF1 induces genomic instability and progressive malignancy in nasopharyngeal carcinoma cells

Sheng-Yen Huang, Chung-Chun Wu, Yu-Jhen Cheng, Sheng-Ping Chou, Yun-Jin Jiang, Kuo-Chang Chu, Ching-Hwa Tsai, Su-Fang Lin, Jen-Yang Chen

ONCOTARGET (2017)

Article Virology

Epstein-Barr Virus BALF3 Has Nuclease Activity and Mediates Mature Virion Production during the Lytic Cycle

Shih-Hsin Chiu, Meng-Chuan Wu, Chung-Chun Wu, Yu-Ching Chen, Su-Fang Lin, John T. -A. Hsu, Chung-Shi Yang, Ching-Hwa Tsai, Kenzo Takada, Mei-Ru Chen, Jen-Yang Chen

JOURNAL OF VIROLOGY (2014)

Article Biochemistry & Molecular Biology

Inhibition of Epstein-Barr Virus Reactivation in Nasopharyngeal Carcinoma Cells by Dietary Sulforaphane

Chung-Chun Wu, Hsin-Ying Chuang, Chao-Yi Lin, Yen-Ju Chen, Wan-Hua Tsai, Chih-Yeu Fang, Sheng-Yen Huang, Fu-Yang Chuang, Su-Fang Lin, Yao Chang, Jen-Yang Chen

MOLECULAR CARCINOGENESIS (2013)

Article Multidisciplinary Sciences

Nuclear Translocation and Regulation of Intranuclear Distribution of Cytoplasmic Poly(A)-Binding Protein Are Distinct Processes Mediated by Two Epstein Barr Virus Proteins

Richard Park, Ayman El-Guindy, Lee Heston, Su-Fang Lin, Kuan-Ping Yu, Mate Nagy, Sumit Borah, Henri-Jacques Delecluse, Joan Steitz, George Miller

PLOS ONE (2014)

Meeting Abstract Oncology

Recapitulation of inflammatory and immune-evasive subtypes of oral cancer cells in immunodeficient mice.

Su-Fang Lin, Ying-Chieh Ko, Fu-Hui Wang, Sheng-Yao Su, Yu-Lian Chen, Ting-Yu Lai, Yi-Hong Liu, Chung-Yen Lin, Shu-Ching Hsu

JOURNAL OF CLINICAL ONCOLOGY (2019)

Article Oncology

MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1

Sung-Tau Chou, Hsuan-Yu Peng, Kuan-Chi Mo, Yuan-Ming Hsu, Guan-Hsun Wu, Jenn-Ren Hsiao, Su-Fang Lin, Horng-Dar Wang, Shine-Gwo Shiah

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Article Oncology

Emodin Inhibits EBV Reactivation and Represses NPC Tumorigenesis

Chung-Chun Wu, Mei-Shu Chen, Yu-Jhen Cheng, Ying-Chieh Ko, Su-Fang Lin, Ing-Ming Chiu, Jen-Yang Chen

CANCERS (2019)

Article Oncology

Discoidin Domain Receptor-1 (DDR1) is Involved in Angiolymphatic Invasion in Oral Cancer

Yu-Lian Chen, Wan-Hua Tsai, Ying-Chieh Ko, Ting-Yu Lai, Ann-Joy Cheng, Shine-Gwo Shiah, Jenn-Ren Hsiao, Jang-Yang Chang, Su-Fang Lin

CANCERS (2020)

Article Oncology

Index of Cancer-Associated Fibroblasts Is Superior to the Epithelial-Mesenchymal Transition Score in Prognosis Prediction

Ying-Chieh Ko, Ting-Yu Lai, Shu-Ching Hsu, Fu-Hui Wang, Sheng-Yao Su, Yu-Lian Chen, Min-Lung Tsai, Chung-Chun Wu, Jenn-Ren Hsiao, Jang-Yang Chang, Yi-Mi Wu, Dan R. Robinson, Chung-Yen Lin, Su-Fang Lin

CANCERS (2020)

Article Medicine, Research & Experimental

c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation

Ya-Chu Tang, Jenn-Ren Hsiao, Shih-Sheng Jiang, Jang-Yang Chang, Pei-Yi Chu, Ko-Jiunn Liu, Hsun-Lang Fang, Li-Mei Lin, Huang-Hui Chen, Yen-Wen Huang, Yu-Tsen Chen, Fang-Yu Tsai, Su-Fang Lin, Yung-Jen Chuang, Ching-Chuan Kuo

Summary: NRF2, up-regulated in HNSCC, correlates positively with malignant features. Carcinogens trigger c-MYC-directed NRF2 activation. NRF2 reprograms cancer metabolic pathways, particularly the PPP, with G6PD and TKT driving malignant progression. The NRF2/G6PD/TKT gene set may serve as a prognostic biomarker for patient overall survival.

THERANOSTICS (2021)

No Data Available